Marburg, Germany

Peter Pfleiderer


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Inventor Peter Pfleiderer**

Introduction

Peter Pfleiderer, an accomplished inventor based in Marburg, Germany, has made significant contributions to the field of biomedical research, specifically in the realm of cancer diagnostics and therapies. With a total of six patents to his name, Pfleiderer's work has paved the way for advancements in the understanding and treatment of various carcinomas.

Latest Patents

Among his notable inventions are two groundbreaking patents focused on monoclonal antibodies against tumor-associated antigens. The first patent details monoclonal antibodies specifically targeting tumor-associated antigens derived from breast, ovarian, and prostate carcinomas as well as adenocarcinomas of the lung. This invention highlights the antibodies' reaction with polymorphic epithelial mucin (PEM), offering promising avenues for both diagnosis and therapy. The second patent focuses on the epitope that binds to monoclonal antibody BW 835, DSM ACC 2022, further emphasizing its utility in diagnostic and therapeutic applications.

Career Highlights

Peter Pfleiderer's career includes affiliations with reputable organizations such as Behringwerke Aktiengesellschaft and Behring Diagnostics GmbH. His involvement in these companies showcases his dedication to advancing healthcare through innovative solutions and research.

Collaborations

Pfleiderer's contributions have been enriched by his collaborations with fellow researchers Klaus Bosslet and Gerhard Seemann. These partnerships have played a crucial role in the development and refinement of his pioneering inventions.

Conclusion

In conclusion, Peter Pfleiderer stands out as a notable figure in the field of biomedical innovation. His patents not only reflect his inventive spirit but also represent significant advancements in the fight against cancer. As he continues his work, his contributions will likely have a lasting impact on cancer diagnostics and therapies, shaping the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…